Equito, Angel .
HRN: 17-51-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/05/2024
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
02/05/2024
02/12/2024
ORAL
1mL
QID
Ora Candidiasis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes